IndraLab

Statements


USP30 inhibits UBD. 1 / 1
| 1

reach
"As expected, Cys and His mutations abrogate USP30 activity, while Ser mutation to Ala, but also to Asn or Asp, that are usually found in USP DUBs XREF_BIBR, reduce activity in both mono- and diubiquitin based substrate cleavage assays (XREF_FIG, XREF_SUPPLEMENTARY)."